St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for St. Jude Medical, Inc
81.70
+0.14 (0.17%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 81.38 - 81.85
52 week 48.83 - 81.86
Open 81.40
Vol / Avg. 1.61M/2.59M
Mkt cap 23.32B
P/E 35.48
Div/yield 0.31/1.52
EPS 2.30
Shares 283.87M
Beta 1.25
Inst. own 78%
Oct 19, 2016
Q3 2016 St. Jude Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 20, 2016
Q2 2016 St. Jude Medical Inc Earnings Release
Jul 20, 2016
Q2 2016 St. Jude Medical Inc Earnings Call
May 6, 2016
St. Jude Medical Inc Annual Shareholders Meeting (Estimated)
Apr 28, 2016
Abbott Laboratories to acquire St. Jude Medical, Inc- M&A Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '16) 2016
Net profit margin 15.24% 15.63%
Operating margin 20.04% 18.59%
EBITD margin - 26.64%
Return on average assets 7.57% 7.45%
Return on average equity 22.78% 21.36%
Employees 18,000 -
CDP Score - -

Address

1 Saint Jude Medical Dr
SAINT PAUL, MN 55117-1789
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Officers and directors

Daniel J. Starks Executive Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael T. Rousseau President, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 47
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 55
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 51
Bio & Compensation  - Reuters
John C. Heinmiller Executive Vice President
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 46
Bio & Compensation  - Reuters
Lisa Malden Andrade Chief Marketing Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
I. Paul Bae Chief Marketing Officer, Vice President - Global Human Resources
Age: 51
Bio & Compensation  - Reuters